Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FRX

Ferrex (FRX)

Ferrex
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FRX
DateTimeSourceHeadlineSymbolCompany
07/19/20227:30AMRNS Non-RegulatoryKeras Resources PLC Update regarding Investor Presentation and GMLSE:FRXFerrex
06/22/202210:20AMRNS Non-RegulatoryKeras Resources PLC New Date - Shareholder/Investor PresentationLSE:FRXFerrex
06/09/20222:03AMRNS Non-RegulatoryKeras Resources PLC Shareholder/Investor Meeting and PresentationLSE:FRXFerrex
06/24/20219:36AMRNS Non-RegulatoryKeras Resources PLC Updated Corporate PresentationLSE:FRXFerrex
10/30/20193:00AMRNS Non-RegulatoryKeras Resources PLC Joint Investor Event - Further DetailsLSE:FRXFerrex
09/14/20187:00AMRNS Non-RegulatoryKeras Resources PLC Investor EventLSE:FRXFerrex
11/23/201710:55AMRNS Non-RegulatoryKeras Resources PLC New Company PresentationLSE:FRXFerrex
11/16/20174:47AMRNS Non-RegulatoryKeras Resources PLC Pilbara Gold Presentation-London 23 November 2017LSE:FRXFerrex
08/01/20172:02AMRNS Non-RegulatoryKeras Resources PLC Brandon Hill ResearchLSE:FRXFerrex
04/12/20167:20AMRNS Non-RegulatoryKeras Resources PLC New Corporate PresentationLSE:FRXFerrex
03/18/20163:00AMRNS Non-RegulatoryKeras Resources PLC Corporate PresentationLSE:FRXFerrex
10/29/20095:54AMDow Jones NewsRichter To Start Late Stage Tests On Key Schizophrenia DrugNYSE:FRXForest Laboratories Inc.
10/29/20094:47AMDow Jones NewsHungary Richter, US Forest Announce Positive Drug TestsNYSE:FRXForest Laboratories Inc.
08/27/20096:31PMPR Newswire (US)Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and ReduceNYSE:FRX
08/19/20099:50AMDow Jones News2nd UPDATE: Glenmark, Forest Say Their Drug Failed In TrialsNYSE:FRXForest Laboratories Inc.
08/19/20093:53AMDow Jones NewsUPDATE: Glenmark, Forest Say Oglemilast Failed In Key StudyNYSE:FRXForest Laboratories Inc.
08/12/20094:32AMDow Jones NewsAstraZeneca, Forest Labs Ink Ceftaroline DealNYSE:FRXForest Laboratories Inc.
08/10/20097:00AMPR Newswire (US)Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPDNYSE:FRX
07/21/20099:08AMDow Jones NewsForest Labs 1Q Net Up 8.2% As Namenda Sales JumpNYSE:FRXForest Laboratories Inc.
06/22/20099:20AMPR Newswire (US)Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and WyndhamNYSE:FRX
06/19/20092:40PMDow Jones NewsForest Labs Reports Upbeat Pneumonia Drug Test ResultsNYSE:FRXForest Laboratories Inc.
06/10/200910:54AMDow Jones NewsPHARMA MARKET: Wyeth Stands By Pristiq After Slow StartNYSE:FRXForest Laboratories Inc.
05/22/20094:34PMDow Jones NewsDrug Makers To Pay $89 Million To Settle Alabama Medicaid Price SuitsNYSE:FRXForest Laboratories Inc.
05/05/200911:03AMDow Jones News2nd UPDATE:Jubilant Organosys Unit In Pact With AstraZenecaNYSE:FRXForest Laboratories Inc.
04/30/20094:01AMDow Jones NewsAlmirall, Forest See New Drug Application For COPD By 2012NYSE:FRXForest Laboratories Inc.
04/21/20099:09AMDow Jones NewsForest Labs 4Q Net Drops 46% Amid Marketing Probe Set-AsideNYSE:FRXForest Laboratories Inc.
04/03/20097:34PMDow Jones NewsUPDATE: FDA Warns World's Largest Drug Firms Over Internet AdsNYSE:FRXForest Laboratories Inc.
04/03/20096:22PMDow Jones NewsFDA Warns World's Largest Drug Firms Over Internet AdsNYSE:FRXForest Laboratories Inc.
03/06/20097:21AMDow Jones NewsFDA Wants More Study On Almirall, Forest Labs COPD DrugNYSE:FRXForest Laboratories Inc.
02/25/20095:24PMDow Jones NewsUPDATE:DOJ:Forest Labs Engaged In Improper Marketing,KickbacksNYSE:FRXForest Laboratories Inc.
 Showing the most relevant articles for your search:LSE:FRX